A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection
Clinical trial NCT05514314 · UNKNOWN
Trial details
- NCT number
- NCT05514314
- Sponsor
- Wu Nan
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2024-09-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.